These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3135955

  • 1. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J, Kruszewski FH, Chenicek KJ.
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants.
    Battalora MS, Kruszewski FH, DiGiovanni J.
    Carcinogenesis; 1993 Dec; 14(12):2507-12. PubMed ID: 8269619
    [Abstract] [Full Text] [Related]

  • 3. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH, Conti CJ, DiGiovanni J.
    Cancer Res; 1987 Jul 15; 47(14):3783-90. PubMed ID: 3109733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
    Kruszewski FH, Chenicek KJ, Digiovanni J.
    Cancer Lett; 1986 Sep 15; 32(3):263-9. PubMed ID: 3768852
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
    DiGiovanni J, Kruszewski FH, Coombs MM, Bhatt TS, Pezeshk A.
    Carcinogenesis; 1988 Aug 15; 9(8):1437-43. PubMed ID: 3402040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 14. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
    Verma AK, Boutwell RK.
    Carcinogenesis; 1980 Mar 15; 1(3):271-6. PubMed ID: 22283009
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK.
    Cancer Res; 1988 Apr 15; 48(8):2168-73. PubMed ID: 3349487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL, Reddig PJ, Dreckschmidt NE, Leitges M, Verma AK.
    Oncogene; 2002 May 16; 21(22):3620-30. PubMed ID: 12032864
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ, Pavone A, Rupp T, Cantu AR.
    Carcinogenesis; 1990 Jan 16; 11(1):129-37. PubMed ID: 2104781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.